5-MeO-2-TMT
200px | |
Systematic (IUPAC) name | |
---|---|
2-(5-methoxy-2-methyl-H-indol-3-yl)-N,N-dimethylethanamine
|
|
Identifiers | |
CAS Number | 67292-68-6 |
PubChem | CID: 49756 |
ChemSpider | 45143 |
ChEMBL | CHEMBL7143 |
Chemical data | |
Formula | C14H20N2O |
Molecular mass | 232.321 g/mol |
|
|
|
|
(verify) |
5-Methoxy-2,N,N-trimethyltryptamine (5-MeO-2,N,N-TMT, 5-MeO-TMT) is a psychoactive drug of the tryptamine chemical class which acts as a psychedelic. It was first synthesized by Alexander Shulgin and reported in his book TiHKAL ("Tryptamines i Have Known And Loved").[1] 5-MeO-TMT is claimed to show psychoactive effects at a dosage of 75-150 mg orally, but these are relatively mild compared to those of other similar compounds. This suggests that while the methyl group on the 2-position of the molecule has impaired the binding of metabolic enzymes like monoamine oxidase (MAO), it is also interfering with binding to and/or activation of the serotonin 5-HT2A receptor, the target responsible for mediating the hallucinogenic effects of such compounds.
See also
- 2,N,N-Trimethyltryptamine (2,N,N-TMT)
- 5-MeO-7-TMT
References
External links
<templatestyles src="Asbox/styles.css"></templatestyles>
- Pages with broken file links
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugboxes with an unspecified ATC code
- Drugs with no legal status
- Psychedelic tryptamines
- Designer drugs
- Hallucinogen stubs